Brendon J. Coventry

7.7k citations

98 papers · 5.1k indexed · 3 hit papers · h-index 27

Oncology top 0.5%
Epidemiology top 2%
Molecular Biology top 5%
Immunology top 2%
Dermatology top 0.5%

Co-authors: John F. Thompson Constantine P. Karakousis Nicola Mozzillo Robert M. Elashoff Daniel F. Roses Donald L. Morton Omgo E. Nieweg Harald J. Hoekstra
Topics: Cutaneous Melanoma Detection and Management (31 papers)Immunotherapy and Immune Responses (21 papers)Cancer Immunotherapy and Biomarkers (17 papers)
Cited by: Oncology Dermatology Biophysics
Journals: New England Journal of Medicine Journal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations: Australia United States Netherlands

In The Last Decade

Brendon J. Coventry

96 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sentinel-Node Biopsy or Nodal Observation in Melanoma

2006 1.2k citations Donald L. Morton, John F. Thompson et al. profile →
Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma

2014 943 citations Donald L. Morton, John F. Thompson et al. profile →
Sentinel Node Biopsy for Early-Stage Melanoma

2005 504 citations Donald L. Morton, Alistair J. Cochran et al. profile →

Peers

Countries citing papers authored by Brendon J. Coventry

Since Specialization

Citations

This map shows the geographic impact of Brendon J. Coventry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brendon J. Coventry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brendon J. Coventry more than expected).

Fields of papers citing papers by Brendon J. Coventry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brendon J. Coventry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brendon J. Coventry. The network helps show where Brendon J. Coventry may publish in the future.

Co-authorship network of co-authors of Brendon J. Coventry

This figure shows the co-authorship network connecting the top 25 collaborators of Brendon J. Coventry. A scholar is included among the top collaborators of Brendon J. Coventry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brendon J. Coventry. Brendon J. Coventry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can C-Reactive Protein (CRP) Time Series Forecasting be Achieved via Deep Learning? 2019 ·IEEE Access ·(unknown),(unknown),(unknown),Andrew Allison,Brendon J. Coventry,Derek Abbott	8
2	Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease 2019 ·Annals of Surgical Oncology ·Abhineet Uppal,(unknown),John F. Thompson,Leland J. Foshag,(unknown),Omgo E. Nieweg,Harald J. Hoekstra,Daniel F. Roses,Vernon K. Sondak,Mohammed Kashani–Sabet,Brendon J. Coventry,Alistair J. Cochran,Manabu Fujita,(unknown),David Elashoff,Robert M. Elashoff,Mark B. Faries	3
3	On detection of periodicity in C-reactive protein (CRP) levels 2018 ·Scientific Reports ·(unknown),(unknown),(unknown),Andrew Allison,Brendon J. Coventry,Derek Abbott	18
4	Australian Multicenter Study of Isolated Limb Infusion for Melanoma 2015 ·Annals of Surgical Oncology ·Hidde M. Kroon,Brendon J. Coventry,(unknown),Michael A. Henderson,David Speakman,(unknown),Andrew P. Barbour,Jonathan W. Serpell,Paul Paddle,(unknown),Thomas Sullivan,B. Mark Smithers,John F. Thompson	23
5	Long-term survival in advanced melanoma patients using repeated therapies: successive immunomodulation improving the odds? 2015 ·Cancer Management and Research ·Brendon J. Coventry,(unknown),(unknown)	7
6	Bradycardia as an early warning sign for cardiac arrest during routine laparoscopic surgery 2015 ·International Journal for Quality in Health Care ·(unknown),Peter Hibbert,W. B. Runciman,Brendon J. Coventry	26
7	Palpation as a useful diagnostic tool for skin lesions 2014 ·Journal of Plastic Reconstructive & Aesthetic Surgery ·(unknown),Peter G. Devitt,Brendon J. Coventry,(unknown)	8
8	Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanoma 2014 ·Journal for ImmunoTherapy of Cancer ·Brendon J. Coventry,(unknown),Peter Hersey,(unknown),Richard Bright	7
9	Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review 2014 ·BMC Neurology ·Richard Bright,Jennifer Wilkinson,Brendon J. Coventry	21
10	Locoregional disease control in metastatic melanoma: Exploratory analysis from phase 2 testing of intralesional rose bengal 2013 ·European Journal of Cancer ·Sanjiv S. Agarwala,John F. Thompson,B. Mark Smithers,M. I. Ross,Brendon J. Coventry,David R. Minor,Charles R. Scoggins,(unknown),Eric A. Wachter	3
11	Australian Multi-Center Study of Isolated Limb Infusion Chemotherapy for Melanoma: Experience Outside of the Sydney Melanoma Unit 2013 ·Queensland's institutional digital repository (The University of Queensland) ·Hidde M. Kroon,Brendon J. Coventry,(unknown),M. Henderson,Jonathan Serpell,B. Mark Smithers	1
12	The 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responses 2012 ·Cancer Management and Research ·Brendon J. Coventry,(unknown)	27
13	Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I) 2012 ·Annals of Surgical Oncology ·John H. Howard,John F. Thompson,Nicola Mozzillo,Omgo E. Nieweg,Harald J. Hoekstra,Daniel F. Roses,Vernon K. Sondak,Douglas S. Reintgen,Mohammed Kashani–Sabet,Constantine P. Karakousis,Brendon J. Coventry,William Kraybill,B. Mark Smithers,Robert M. Elashoff,Stacey L. Stern,Alistair J. Cochran,Mark B. Faries,Donald L. Morton	125
14	Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation 2012 ·Cancer Management and Research ·Brendon J. Coventry,(unknown)	19
15	The geography of melanoma in South Australia 2009 ·Australian and New Zealand Journal of Public Health ·Adrian R Heard,Brendon J. Coventry,(unknown),(unknown)	4
16	CD1a in human cancers: a new role for an old molecule 2004 ·Trends in Immunology ·Brendon J. Coventry,Susanne Heinzel	58
17	Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma 2004 ·Cancer Immunology Immunotherapy ·Peter Hersey,Scott W. Menzies,Brendon J. Coventry,Tam Nguyen,Margaret Farrelly,Susan Collins,(unknown),Heather Johnson	42
18	Dendritic cell density and activation status in human breast cancer – CD1a, CMRF-44, CMRF-56 and CD-83 expression 2002 ·British Journal of Cancer ·Brendon J. Coventry,(unknown),David D. Gibbs,Derek N.J. Hart	58
19	Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours 1999 ·British Journal of Cancer ·(unknown),(unknown),Brendon J. Coventry	55
20	The utility of the proliferative index in pretreatment biopsy specimens of esophageal squamous cell carcinoma 1998 ·Diseases of the Esophagus ·Xu Dong Zhang,Brendon J. Coventry,G. G. Jamieson,P. Grantley Gill	6

About Brendon J. Coventry

Brendon J. Coventry is a scholar working on Oncology, Microbiology and Immunology, having authored 98 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (31 papers), Immunotherapy and Immune Responses (21 papers) and Cancer Immunotherapy and Biomarkers (17 papers). The work is most often cited by research in Oncology (3.8k citations), Dermatology (548 citations) and Biophysics (308 citations). Brendon J. Coventry has collaborated with scholars based in Australia, United States and Netherlands. Frequent co-authors include John F. Thompson, Constantine P. Karakousis, Nicola Mozzillo, Robert M. Elashoff, Daniel F. Roses, Donald L. Morton, Omgo E. Nieweg, Harald J. Hoekstra, Douglas S. Reintgen and Alistair J. Cochran. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact